# GE HealthCare

Source: https://onco.cc/companies/ge-healthcare/  
OnCo record `ge-healthcare` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

GE HealthCare, of Chicago, makes PET/CT, MRI and CT scanners (Omni Legend, SIGNA, Revolution) and PET tracers through its Pharmaceutical Diagnostics business, including Cerianna, the fluoroestradiol F-18 agent that images oestrogen receptors in breast cancer. Whether receptor-imaging tracers change treatment decisions often enough to be reimbursed is its tracer business's open question.

## Summary

GE HealthCare, based in Chicago and listed as GEHC, makes PET/CT, MRI and CT scanners and PET tracers through its Pharmaceutical Diagnostics business. Its scanners include the Omni Legend PET/CT, SIGNA MRI and Revolution CT, and its tracer business spans flurpiridaz, cyclotrons and Cerianna, the fluoroestradiol F-18 agent for imaging oestrogen receptor expression in breast cancer. OnCo links it to PET/CT, MRI and CT, to medical cyclotrons and total-body PET hardware, and to the fluoroestradiol F-18 drug record. Whether receptor-imaging tracers such as FES change treatment decisions often enough to be reimbursed widely is the open question for its tracer business. Fluoroestradiol F-18 has its own page.

## Fields

- Kind: Company
- Last checked: 2026-09-04
- HQ: Chicago, IL
- Type: imaging
- Website: https://www.gehealthcare.com
- Ticker: GEHC

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/GE_HealthCare
- Official website: https://www.gehealthcare.com

## Connected records

- fronts: [Imaging](https://onco.cc/fronts/imaging/)
- technologies: [Breast MRI coils and abbreviated breast MRI](https://onco.cc/technologies/breast-mri-coils-abbreviated-mri/), [Contrast-enhanced mammography](https://onco.cc/technologies/contrast-enhanced-mammography/), [CT (computed tomography)](https://onco.cc/technologies/ct/), [CT, MRI and PET scanner manufacturing](https://onco.cc/technologies/medical-imaging-scanner-manufacturing/), [Cyclotron isotope production (F-18, Ga-68, Cu-64, Zr-89, At-211)](https://onco.cc/technologies/cyclotron-isotope-production/), [Dual-energy and spectral CT](https://onco.cc/technologies/dual-energy-spectral-ct/), [Elastography and contrast-enhanced ultrasound](https://onco.cc/technologies/ultrasound-elastography-ceus/), [FES PET (oestrogen receptor imaging)](https://onco.cc/technologies/fes-pet/), [Hand-held and point-of-care ultrasound](https://onco.cc/technologies/hand-held-ultrasound/), [Intraoperative MRI and CT](https://onco.cc/technologies/intraoperative-mri-ct/), [Mammography & tomosynthesis](https://onco.cc/technologies/mammography/), [Medical cyclotrons, hot cells, and synthesis modules](https://onco.cc/technologies/medical-cyclotrons-synthesis-modules/), [MRI](https://onco.cc/technologies/mri/), [MRI field strengths: 1.5 T, 3 T and 7 T](https://onco.cc/technologies/mri-field-strengths/), [Nuclear medicine and total-body PET hardware](https://onco.cc/technologies/nuclear-medicine-hardware/), [PET/CT](https://onco.cc/technologies/pet-ct/), [PET/MRI](https://onco.cc/technologies/pet-mri/), [Photon-counting CT](https://onco.cc/technologies/photon-counting-ct/), [SPECT & bone scan](https://onco.cc/technologies/spect/), [SPECT/CT](https://onco.cc/technologies/spect-ct/), [Strain echocardiography (global longitudinal strain)](https://onco.cc/technologies/strain-echocardiography-gls/), [Ultrasound](https://onco.cc/technologies/ultrasound/), [X-ray radiography and fluoroscopy](https://onco.cc/technologies/x-ray-radiography-fluoroscopy/)
- trials: [Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, o](https://onco.cc/trials/nct07219238/)
- drugs: [Fluoroestradiol F-18 (FES PET)](https://onco.cc/drugs/fluoroestradiol-f18/)

---
JSON: https://onco.cc/api/v1/entities/ge-healthcare.json